Full-Time

Senior Director

Clinical Science Liaisons

Confirmed live in the last 24 hours

Pliant Therapeutics

Pliant Therapeutics

51-200 employees

Develops treatments for fibrotic diseases

Biotechnology
Healthcare

Compensation Overview

$280k - $290kAnnually

Senior

San Bruno, CA, USA

Field-based or local position in South San Francisco.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Advanced degree or equivalent (e.g., PA/MPH/DO/MD/PharmD/PhD) with approximately 3-4 years of clinical trial and/or R&D experience, including 12+ years in a CTL, CSL, MSL, or comparable position
  • 8+ years of experience managing direct reports, demonstrating effective teamwork, proven leadership, and hands-on coaching and management.
  • Ability to travel domestically and internationally up to 30%, including travel to South San Francisco headquarters at least 6 times/year and for key departmental and/or company meetings, as needed
  • Working knowledge of protocol and clinical drug development processes, clinical study design, study planning and management, and monitoring data
  • Track record of demonstrating solid 'leadership behaviors'
  • Well-developed interpersonal and people-management skills, as well as effective communication
  • High attention to detail and the capability to understand the 'overarching' perspective
  • Established capacity to define priorities and manage several demands simultaneously
  • Ability to analyze critically and practice resourcefulness and initiative
  • Ability to work independently while demonstrating initiative, adaptability, and adept judgment
  • Comfortable working at all levels of the organization, including senior stakeholders
  • Demonstrated proficiency in Microsoft Word, PowerPoint, and Excel
  • Ability to demonstrate Pliant’s values
Responsibilities
  • Serve as a people leader for the global clinical science liaison team, training and empowering the team to co-develop, manage, and implement strategic plans to support clinical trial education, recruitment, enrollment, and retention.
  • Provide global functional leadership, creating effective processes and engagement plans that are customized as needed for global regions and delegating team tasks as applicable.
  • Lead budget review, negotiation, and payment approvals for functional service provision of CSLs supporting Pliant’s development portfolio.
  • Develop training materials and instructions to support CSL team actions and responsibilities.
  • Develop clinical site engagement communications and presentations for site initiation, office visits, investigator meetings, advisory boards to enhance current and future clinical trial awareness.
  • Identify and communicate key clinical trial issues and insights to the VP, Clinical Operations, and any other appropriate functional stakeholders to help influence clinical trial execution including, but not limited to, site identification, site start-up, patient screening and recruitment, and patient retention.
  • Oversee and drive the CSLs’ education, analysis, and resolution of issues with clinical study sites and investigators to support efforts to improve recruitment and activation timelines.
  • Collaborate with Development Operations, Clinical Development, and external stakeholders to support clinical needs and monitor study performance and progress.
  • Facilitate identification of clinical trial site and community educational needs for Pliant clinical trials.
  • Attends scientific and medical congresses, and professional conferences.
  • Participate in Pliant community outreach and engagement activities.
  • Maintain business and clinical knowledge of the treatment landscape including current treatment strategies, current and pending competitors, and new therapeutic developments.

Pliant Therapeutics develops treatments for fibrotic diseases, which cause thickening and scarring of connective tissue, leading to organ dysfunction. Their products work by targeting the biological mechanisms behind fibrosis, particularly through the inhibition of integrins, which are proteins that help cells stick together and communicate. This targeted approach allows Pliant to create effective treatments for various fibrotic conditions. Unlike many competitors, Pliant focuses specifically on the science of fibrosis and integrin biology, aiming to reverse the effects of these diseases rather than just manage symptoms. The company's goal is to halt the progression of fibrotic diseases and restore normal organ function, ultimately improving the quality of life for patients.

Company Stage

IPO

Total Funding

$694.9M

Headquarters

San Francisco, California

Founded

2015

Growth & Insights
Headcount

6 month growth

6%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Pliant's accelerated development of bexotegrast for IPF and positive Phase 2a trial results indicate strong potential for successful market entry.
  • The company's participation in high-profile investor events and scientific congresses enhances its visibility and credibility in the biotech community.
  • Recent strategic appointments, including a new Chief Development Officer and Chief Regulatory Officer, bolster Pliant's leadership team and operational capabilities.

What critics are saying

  • The high costs and long timelines associated with drug development pose financial risks, especially if clinical trials do not meet endpoints.
  • The competitive landscape in biopharmaceuticals, particularly in fibrosis treatment, requires Pliant to continuously innovate to maintain its edge.

What makes Pliant Therapeutics unique

  • Pliant Therapeutics focuses specifically on fibrotic diseases, leveraging deep expertise in fibrosis and integrin biology, unlike competitors with broader therapeutic areas.
  • Their targeted approach to integrin inhibition offers a unique mechanism of action that sets them apart from other fibrosis treatments.
  • Pliant's commitment to rigorous clinical trials and data-driven development ensures high standards of efficacy and safety, distinguishing them in the biopharmaceutical market.

Help us improve and share your feedback! Did you find this helpful?